1Nagata S, Golstein P. The Fas death factor[J]. Science,1995.267(5203): 1449-1456.
2Jakubowski A, Browning B, Lukashev M, et al. Dual role for TWEAK in angiogenic regulation[J]. J Cell Sci,2002,115(2):267-274.
3Lynch CN, Wang Y, Lund JK, et al. TWEAK induces angiogenesis and proliferation of endothelial cells[J]. J Biol Chem,1999,274(13):8455-8459.
4Chicheportiche Y, Chicheportiche R, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis actor family that weakly induces apoptosis[J]. J Biol Chem, 1997,272(51):32401-32410.
5Marsters SA, Sheridan JP, Pitti RM, et al. Identification of a ligand for the death-domain-containing receptor Apo3 [J]. Curr Biol, 1998,8:525-528.
6Kitson J, Raven T, Jiang YP, et al. A deth-domain -containing receptor that mediates apoptosis[J]. Nature,1996,384(6607):372.
7Bodmer JL,Burns k Schneider P,et al.TRAMP,a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95)[J]. Immunity,1997,6(1):79-88.
8Screaton GR, Xu XN, Olsea AL, et al. LARD:a new lymphoid -specific death domain containing receptor by alternative pre-mRNA splicing [J]. Proc Natl Acad Sci USA,1997,94(9):4615.
9Kaptein A, Jansen M. Dilaver G, et al. Studies on the interaction between TWEAK and death receptor WSL-1/TRAMP(DR3)[J]. FEBS Lett 2000,485(2-3):135-141.
10Schneider P, Schwenzer R, Haas E, et al. TWEAK can induce cell death via endogenous TNF and TNF receptor [J]. Eur J Immunol,1999,29(6):1785-1792.
同被引文献29
1VAN KIMMENADE R R,JANUZZI J J.Emerging biomarkers in heart failure[J].Clin Chem,2012,58(1):127-138.
2REN M Y,SUI S J.The role of TWEAK/Fn14 in cardiac remodeling[J].Mol Biol Rep,2012,39(11):9971-9977.
3CHORIANOPOULOS E,ROSENBERG M,ZUGCK C,et al.Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure[J].Eur J Heart Fail,2009,11(11):1050-1056.
4HASEGAWA K,IWAI KANAI E,SASAYAMA S.Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure[J].J Cell Physiol,2001,186(1):11-18.
5LEE D S,AUSTIN P C,ROULEAU J L,et al.Predicting mortality among patients hospitalized for heart failure:derivation and validation of a clinical model[J].JAMA,2003,290(19):2581-2587.
6CHICHEPORTICHE Y,BOURDON P R,XU H,et al.TWEAK,a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis[J].J Biol Chem,1997,272(51):32401-32410.
7RICHTER B,RYCHLI K,HOHENSINNER P J,et al.Diffe rences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure[J].Atherosclerosis,2010,213(2):545-548.
8JAIN M,JAKUBOWSKI A,CUI L,et al.A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure[J].Circulation,2009,119(15):2058-2068.
9BOVER L C,CARDO VILA M,KUNIYASU A,et al.A previously unrecognized protein-protein interaction between TWEAK and CD163:potential biological implications[J].J Immunol,2007,178(12):8183-8194.
10MUNOZ GARCIA B,MADRIGAL-MATUTE J,MORENO J A,et al.TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells[J].Cardiovasc Res,2011,89(1):225-233.
